Purchase Order W81K0018P0301
Award Date
10/1/18
Potential Completion Date
9/30/23
Potential Value
$766K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Ortho-Clinical Diagnostics Inc.
Ultimate Awardee
Ortho-Clinical Diagnostics, Inc.
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Greece, NY 14626, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Health Agency awarded Ortho-Clinical Diagnostics Inc. a $188,274.90 delivery order under the Critical Analyzers, Laboratory (FSS-66-III) indefinite-delivery vehicle. The order is for MTS ABD MONO & REV GRP products to support healthcare programs in Greece, with performance at the specified location through September 2024. As a manufacturer of diagnostic solutions including immunodiagnostic and clinical chemistry systems, Ortho-Clinical Diagnostics will provide the requested...
This is a $201,077.28 firm fixed price purchase order awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc. to provide chemistry analyzer maintenance and services. The contract has an ultimate completion date of September 30, 2027. Ortho-Clinical Diagnostics is a medical equipment manufacturing company that supports various federal agencies with diagnostic solutions and laboratory services. This contract does not have a set-aside designation. The award is part of...
The U.S. Defense Health Agency awarded a $165,305.29 delivery order to Ortho-Clinical Diagnostics Inc., a medical equipment manufacturing company, for the provision of laboratory supplies. The contract has a completion date of September 30, 2021 and is a firm fixed price agreement. Ortho-Clinical Diagnostics Inc. provides a wide range of diagnostic solutions, including COVID-19 tests and immunodiagnostic/clinical chemistry systems, to various federal healthcare programs. The company has prior...
The Defense Health Agency awarded a $172,504.53 firm fixed price delivery order to Ortho-Clinical Diagnostics Inc. for the provision of VITROS 5600/XT7600 analyzers, consumables, and cost-per-reportable services for one year. The order is not associated with a set-aside program. Ortho-Clinical Diagnostics is a for-profit medical equipment manufacturer that has provided diagnostic solutions, laboratory equipment, and testing services to various federal healthcare agencies. This delivery order...
This federal contract award from the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics GMBH, a for-profit international organization, is for the lease of a chemistry analyzer, full service, and delivery of reagents. The firm-fixed-price purchase order has a ceiling value of $395,085.56 and a period of performance through September 29, 2025. The contract is not designated as a set-aside. Ortho-Clinical Diagnostics GMBH is a critical supplier of advanced medical diagnostic technologies,...
This is a $1,180,281.57 firm fixed-price purchase order contract awarded by the Defense Health Agency to Ortho-Clinical Diagnostics Inc., a for-profit medical equipment manufacturer and self-certified HUBZone joint venture based in Rochester, New York. The contract is for the provision of clinical chemistry reagents, with a performance period from October 1, 2021 through September 30, 2026. The contract was awarded without a set-aside designation and is not associated with a larger contract...
This is a $3,925.00 firm fixed-price purchase order awarded by the U.S. government to Ortho-Clinical Diagnostics Inc., a for-profit medical equipment manufacturer and self-certified HUBZone joint venture. The contract, which has no set-aside designation, was awarded on February 2, 2007 with a final completion date of September 7, 2007. The place of performance is in Greece, New York. Ortho-Clinical Diagnostics is a supplier of diagnostic solutions to the federal government, specializing in...
The Defense Health Agency awarded a firm fixed price purchase order to Ortho-Clinical Diagnostics Inc. for $170,317.80 to provide annual reagent shipments for the Walter Reed National Military Medical Center in Bethesda, Maryland. This contract has a completion date of September 8, 2026. Ortho-Clinical Diagnostics is a for-profit medical equipment manufacturer that has received numerous federal contracts and task orders to provide diagnostic instruments, reagents, and laboratory supplies to...
The U.S. Department of Defense's Medical Supply Chain agency awarded Ortho-Clinical Diagnostics, Inc. a $2,298.68 fixed-price with economic price adjustment delivery order contract for the supply of medical control reagents. The contract has a performance period ending on November 29, 2024. Ortho-Clinical Diagnostics is a medical equipment manufacturer that provides a range of diagnostic solutions, including products and services to federal agencies such as the Department of Veterans Affairs,...
This is a $306,440.38 firm fixed price delivery order awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc. for chemistry analyzers and lab reagents. The contract is under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule and has a period of performance through June 30, 2026. Ortho-Clinical Diagnostics is a for-profit medical equipment manufacturer that has previously provided diagnostic solutions, reagents, and services to federal agencies including the...